Categories: News

Vantage Shines as Titanium Sponsor at Money Expo Chile 2025

PORT VILA, Vanuatu, Sept. 16, 2025 /PRNewswire/ — Vantage Markets proudly participated as a Titanium Sponsor at Money Expo Chile 2025, one of the country’s first major financial expo, held at Espacio Riesco in Santiago on August 27–28, 2025.

- Advertisement -

The expo provided a platform for Vantage to connect with fintech experts, brokers, and technology providers, strengthening its presence within the financial technology and brokerage sector. Vantage was honored with the “Most Trusted Broker 2025” award, in recognition of its commitment to transparency, reliability, and client trust.

- Advertisement -

On the main stage, Raúl Cabrera, Business Development Manager at Vantage, delivered a keynote titled “The Future of the LATAM Trader: Business, Community, Impact”, where he explored regional trends shaping the trading landscape. Rodrigo Martínez, Business Development Team Lead, participated in a panel discussion on “AI Integration Strategies in Trading Operations”, offering perspectives on how emerging technologies particularly artificial intelligence are transforming trading practices.

- Advertisement -

During the event, attendees engaged in an interactive roulette activity, where they had the opportunity to win official Vantage merchandise, vouchers, or participate in a trivia contest for exclusive prizes.

- Advertisement -

Marc Despallieres, CEO of Vantage Markets, commented: “Being recognized as the ‘Most Trusted Broker’ award at Money Expo Chile reflects our dedication to transparency and strong industry relationships. Money Expo Chile was an important milestone for us to showcase not only our innovation but also the trust we’ve worked hard to earn.”

- Advertisement -

Vantage remains committed to empowering the trading community through education, innovation and transparency.  Visit Vantage Markets,  to stay updated on future events and initiatives.

- Advertisement -

About Vantage

- Advertisement -

Vantage Markets (or Vantage) is a multi-asset CFD broker offering clients access to a nimble and powerful service for trading Contracts for Difference (CFDs) products, including Forex, Commodities, Indices, Shares, ETFs, and Bonds.

- Advertisement -

With over 15 years of market experience, Vantage transcends the role of broker, providing a reliable trading platform, an award-winning mobile trading app, and a user-friendly trading platform that provide clients access to trading opportunities.

- Advertisement -

trade smarter @vantage

- Advertisement -

RISK WARNING: CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. Ensure you understand the risks before trading.

- Advertisement -

Disclaimer: This article is provided for informational purposes only and does not constitute financial advice, a recommendation, an offer, or solicitation to buy or sell any financial products or services. The content is not intended for residents of any jurisdiction where such distribution or use would be contrary to local law or regulation. Readers are strongly advised to seek independent professional advice before making any investment or financial decisions. Any reliance placed on the information presented is strictly at the reader’s own risk.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2773887/Vantage_Shines_Titanium_Sponsor_Money_Expo_Chile_2025.jpg
Photo – https://mma.prnewswire.com/media/2773888/Vantage_Shines_Titanium_Sponsor_Money_Expo_Chile_2025_1.jpg
Logo – https://mma.prnewswire.com/media/1745281/Vantage_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/vantage-shines-as-titanium-sponsor-at-money-expo-chile-2025-302557500.html

- Advertisement -
PRNW Agency

Recent Posts

Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer

Board-certified oncologist who brings over 20 years of senior clinical development experience across large pharmaceutical,…

53 minutes ago

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease

Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in…

53 minutes ago

ROYAL CARIBBEAN UNVEILS THE NEW LEGEND OF THE SEAS WITH NEXT-LEVEL FAMILY EXPERIENCES

The Icon Class vacation sets the bar with more dining spots, new entertainment and ways…

2 hours ago

Jetcraft grows US footprint with new Sales Director appointment

 RALEIGH, N.C., Oct. 6, 2025 /PRNewswire/ -- Jetcraft, the global leader in business aircraft sales, acquisitions…

2 hours ago

Home Centre unveils its Diwali Collection with The Great Indian Diwali Gourmet Table with Chef Ranveer Brar

NEW DELHI, Oct. 6, 2025 /PRNewswire/ -- Home Centre, India's most preferred destination for homemakers…

4 hours ago

CeraVe Becomes NBA’s Official Skincare Partner

P artnership to Promote Dermatologist-Developed Skincare Through Season-Long Campaigns and Community Initiatives NEW YORK, Oct.…

4 hours ago